Labshake search
Citations for Stemcell Technologies :
251 - 300 of 1469 citations for 5 1 3 benzothiazol 2 ylamino pentanoic acid since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2023Quote: ... 3 μM CHIR99021 (Chir) (Catalog no. 72054, Stem Cell Technologies), 1 μM PD0305901 (Catalog no ...
-
Pluripotent stem cell SOX9 and INS reporters facilitate differentiation into insulin-producing cellsbioRxiv - Developmental Biology 2021Quote: ... 5 ng/ml FGF7 (Stem Cell Technologies), 2 µM IWR-1 (Selleck Chemicals ...
-
bioRxiv - Cell Biology 2021Quote: ... suplemented with 5% FBS (StemCell Technology, 06200) and the same reagents and cytokine cocktail than the methylcellulose assays (full cytokine medium) ...
-
bioRxiv - Microbiology 2022Quote: ... 5 μM Y-27632 (Stem Cell Technologies), 1 μM A-83-01 (Tocris) ...
-
bioRxiv - Neuroscience 2021Quote: ... 5 mM L-Glutamine (Stemcell Technologies; 07100), and 35 μg/ml L-Glutamic Acid (Sigma Aldrich ...
-
bioRxiv - Neuroscience 2022Quote: ... supplemented with mTeSR1 5× Supplement (StemCell Technologies), ensuring the colony sizes were around 50-100 μm in diameter ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5 μM SB-431542 (StemCell Technologies, 72234), and 1 μM LDN-193189 (StemCell Technologies ...
-
bioRxiv - Neuroscience 2023Quote: ... 5 mM L-glutamine (STEMCELL Technologies, 07100), and 35 μg ml-1 of L-glutamic acid (Sigma-Aldrich ...
-
bioRxiv - Bioengineering 2023Quote: ... containing 5 μM IWP4 (STEMCELL Technologies, 72552). An additional 48 hours later (on Day 5) ...
-
bioRxiv - Neuroscience 2023Quote: ... 5 µM FSK (STEMCELL Technologies, #100-0249) and 200 ng/ml NRG1 type III ...
-
bioRxiv - Bioengineering 2024Quote: ... and 5 μM CHIR99021 (StemCell Technologies, 72054). After 48h ...
-
bioRxiv - Neuroscience 2024Quote: ... 5 μM IWP2 (ref.72124, Stemcell Technologies) from day 0 to 7 and 50 ng/mL FGF8 (ref.100-32 ...
-
bioRxiv - Cell Biology 2020Quote: ... at 37°C for 5 minutes and replated in a ratio of 1:6 or 1:9 on new Matrigel-coated plates in E8 supplemented with 5 μM ROCK inhibitor Y-27632 (Stemcell Technologies, Canada) for 24h ...
-
bioRxiv - Molecular Biology 2022Quote: ... The differentiation was started following 24 h of seeding and proceeded through a 7-stage differentiation protocol (stages 1 – 4 in adherent culture, stage 5 in AggreWell (Stemcell Technologies, #34421), and stages 6 and 7 in suspension culture).
-
bioRxiv - Genetics 2024Quote: ... CD34+ HSPCs were cultured at 1×105–5×105 cells/mL in StemSpan Serum-Free Expansion Medium II (STEMCELL Technologies, Vancouver, Canada) or Good Manufacturing Practice Stem Cell Growth Medium (SCGM ...
-
bioRxiv - Developmental Biology 2023Quote: ... The cell culture medium was supplemented with 1:200 Rho-associated protein kinase inhibitor (ROCKi) Y-27632 (final concentration 5 µM, STEMCELL Technologies, 72302) on the first day after passage ...
-
bioRxiv - Cell Biology 2023Quote: ... The hESCs H1 cell-lines were differentiated using the extended 7-stage protocol (stages 1–4 in adherent culture, stage 5 in AggreWell (Stemcell Technologies, #34421), and stages 6 and 7 in suspension culture).
-
bioRxiv - Immunology 2024Quote: ... the cells were pelleted at 200 rcf for 5 min and resuspended in 1 ml of Neurosphere Proliferation Medium consisting of NeuroCult Basal Medium (StemCell Tech 05700) containing 5 mL NeuroCult Proliferation Supplement (StemCell Tech 05701) ...
-
bioRxiv - Immunology 2024Quote: ... BMDCs were washed and stained for flow cytometry or co-cultured at a 1:5 ratio with CFDA-SE (Stemcell Technologies, Canada) -labelled CD4 T cells isolated from a B6 ...
-
bioRxiv - Cell Biology 2023Quote: ... 5% CO2) at a cell concentration of 5 × 105/mL in StemSpan Serum-Free Expansion Medium II (STEMCELL Technologies) supplemented with 100 ng/mL of human recombinant SCF ...
-
bioRxiv - Cell Biology 2023Quote: ... hiPSCs and hESCs were cultured in mTESR-Plus medium (StemCell Technologies at 5% O2, 5% CO2 and 37 °C). The cells were characterized based on expression of stemness markers (Oct4 ...
-
bioRxiv - Bioengineering 2021Quote: ... microcapsules carrying HUES-8 cells were immersed in E8 medium for 1 h immediately after encapsulation and then transferred into E6 medium (without FGF-2 and TGF-β1, STEMCELL Technologies) for subsequent cultivation (2000 microcapsules per well) ...
-
bioRxiv - Cancer Biology 2022Quote: ... Tissues were cut into 1-2 mm pieces and subsequently incubated in serum-free medium containing collagenase/hyaluronidase (Stem Cell Technologies) at 37 ºC ...
-
bioRxiv - Immunology 2024Quote: ... were differentiated into TH2 T cell subtype by incubation with specific supplement for TH2 differentiation (mouse IL-2, mouse IL-4 and rat anti mouse IFNγ with 1:100 dilution (STEMCELL Technologies)) and incubated for 3 days on plates coated with aCD3 and aCD28 antibodies ...
-
bioRxiv - Cancer Biology 2023Quote: ... co-cultures were counted and recultured as 1 x 106 cells/ml in fresh medium containing 20 U/ml recombinant human IL-2 (StemCell Technologies) in the presence of soquelitinib or DMSO for additional 5 days ...
-
bioRxiv - Bioengineering 2023Quote: ... The PBMC pellet was resuspended in PBS supplemented with 2% FBS and 1 mM EDTA and monocyte isolation was performed using the EasySepTM human monocyte isolation kit (Stemcell Technologies) according to manufacturer instructions ...
-
bioRxiv - Cancer Biology 2024Quote: Tissue samples of ovarian tumours were cut into ∼1-2 mm3 pieces using sterile scalpels and digested with collagenase type IV (STEMCELL Technologies) for 2 hours at 37°C on a rotator ...
-
bioRxiv - Physiology 2024Quote: ... and N2B27 supplemented with 2 ng/ml Activin A and 2 µg/ml Heparin (STEMCELL Technologies) for 5 days ...
-
bioRxiv - Genomics 2024Quote: ... and N2B27 supplemented with 2 ng/ml Activin A and 2 µg/ml Heparin (STEMCELL Technologies) for 5 days ...
-
bioRxiv - Neuroscience 2023Quote: ... the natural developmental signaling factors were recapitulated with small molecules including Ascorbic acid (72132, StemCell technologies), CHIR99021 (72054 ...
-
bioRxiv - Bioengineering 2021Quote: ... 2 μg/ml Heparin (STEMCELL Technologies), 20 ng/ml bFGF (Millipore) ...
-
bioRxiv - Cancer Biology 2020Quote: ... 2 μg/ml heparin (StemCell Technologies), epidermal growth factor (EGF ...
-
bioRxiv - Neuroscience 2020Quote: ... 2% NeuroCult SM1 supplement (STEMCELL Technologies), 2 mM GlutaMax.
-
bioRxiv - Developmental Biology 2020Quote: ... 10ng/mL FGF-2 (StemCell Technology), and 5nM Rock inhibitor ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 µM SB431542 (StemCell Technologies). Cells were maintained in NbM for 6 days after which they were passaged with 1 U/mL Dispase (StemCell Technologies ...
-
bioRxiv - Neuroscience 2023Quote: ... 2% SM1 (Stemcell Technologies, Vancouver, Canada), and 5 μM cytosine β-d-arabinofuranoside (AraC ...
-
bioRxiv - Cancer Biology 2023Quote: ... 2 μg/ml heparin (Stemcell Technologies), 50 units/ml penicillin ...
-
bioRxiv - Neuroscience 2023Quote: ... B27 (2%v/v, Stemcell technologies), N2 (0.5%v/v ...
-
bioRxiv - Neuroscience 2024Quote: ... 2% NeuroCult SM1 (Stemcell technologies, 05711), 1% penicillin/streptomycin (Thermo Fisher Scientific ...
-
bioRxiv - Neuroscience 2024Quote: ... and XAV939 (STEMCELL Technologies; 2 µM) were added in NM for 6 days ...
-
bioRxiv - Neuroscience 2024Quote: ... 2% NeuroCult SM1 (Stemcell technologies, 05711), 2% HyClone™ Fetal Bovine Serum (Thermo Fisher Scientific ...
-
bioRxiv - Developmental Biology 2024Quote: ... 2 μM CHIR99021 (STEMCELL Technologies, 72054), 0.5 μM A83-01 ...
-
bioRxiv - Cell Biology 2024Quote: ... 2% PB plasma (STEMCELL Technologies, 70039), 10 µg/mL insulin (Sigma-Aldrich ...
-
bioRxiv - Cancer Biology 2021Quote: ... in the same 3:4 mixture of media (StemCell Technologies #05620) and Matrigel (BD Bioscience CB-40324) ...
-
bioRxiv - Cell Biology 2021Quote: ... and IL-3 (1ng/mL first day only; Stemcell Technologies; Canada). Cell density was maintained between 0.7-2×106 cells/mL (CASY Model TCC ...
-
bioRxiv - Cancer Biology 2022Quote: ... recombinant Fms-like tyrosine kinase-3 (Flt3, StemCell Technologies Cat#78009), Erythropoeitin (EPO ...
-
bioRxiv - Neuroscience 2022Quote: ... and passaged every 3-4 days using ReLeSR (Stem Cell Technologies) until neural induction ...
-
bioRxiv - Neuroscience 2022Quote: ... and passaged every 3-4 days using ReLeSR (Stem Cell Technologies). Human iPSCs were edited for homozygous knockout of TAOK2 or heterozygous knock-in of the A135P mutation as described in Deneault et al.(Deneault et al. ...
-
bioRxiv - Cell Biology 2022Quote: ... and 3 µM of CHIR99021 (GSK3B inhibitor, STEMCELL Technologies, cat # 72054). From day 1 to 3 ENR was supplemented with 20% Wnt3a-CM and 10 μM Y-27632.
-
bioRxiv - Neuroscience 2022Quote: ... 3×106 single-cell suspension (Gentle Cell Dissociation Reagent, StemCell Technologies) of iPSCs were plated ...